BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33229526)

  • 21. Structure-Activity Study of Antibacterial Poly(ester urethane)s with Uniform Distribution of Hydrophobic and Cationic Groups.
    Peng C; Vishwakarma A; Mankoci S; Barton HA; Joy A
    Biomacromolecules; 2019 Apr; 20(4):1675-1682. PubMed ID: 30844254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.
    Lee HR; You DG; Kim HK; Sohn JW; Kim MJ; Park JK; Lee GY; Yoo YD
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel cationic peptide TP359 down-regulates the expression of outer membrane biogenesis genes in Pseudomonas aeruginosa: a potential TP359 anti-microbial mechanism.
    Dosunmu EF; Chaudhari AA; Bawage S; Bakeer MK; Owen DR; Singh SR; Dennis VA; Pillai SR
    BMC Microbiol; 2016 Aug; 16(1):192. PubMed ID: 27549081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Broad-Spectrum Bactericidal Activity of a Synthetic Random Copolymer Based on 2-Methoxy-6-(4-Vinylbenzyloxy)-Benzylammonium Hydrochloride.
    Schito AM; Piatti G; Caviglia D; Zuccari G; Alfei S
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria.
    Tram NDT; Selvarajan V; Boags A; Mukherjee D; Marzinek JK; Cheng B; Jiang ZC; Goh P; Koh JJ; Teo JWP; Bond PJ; Ee PLR
    Acta Biomater; 2021 Nov; 135():214-224. PubMed ID: 34506975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.
    Li SA; Liu J; Xiang Y; Wang YJ; Lee WH; Zhang Y
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3144-50. PubMed ID: 24637683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next generation of antimicrobial peptides as molecular targeted medicines.
    Aoki W; Kuroda K; Ueda M
    J Biosci Bioeng; 2012 Oct; 114(4):365-70. PubMed ID: 22658802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Mechanism of Killing by the Proline-Rich Peptide Bac7(1-35) against Clinical Strains of Pseudomonas aeruginosa Differs from That against Other Gram-Negative Bacteria.
    Runti G; Benincasa M; Giuffrida G; Devescovi G; Venturi V; Gennaro R; Scocchi M
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137800
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates.
    Liu CB; Shan B; Bai HM; Tang J; Yan LZ; Ma YB
    Dongwuxue Yanjiu; 2015 Jan; 36(1):41-7. PubMed ID: 25730460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria.
    Yarlagadda V; Manjunath GB; Sarkar P; Akkapeddi P; Paramanandham K; Shome BR; Ravikumar R; Haldar J
    ACS Infect Dis; 2016 Feb; 2(2):132-9. PubMed ID: 27624964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa.
    Kim H; Jang JH; Kim SC; Cho JH
    Eur J Med Chem; 2020 Jan; 185():111814. PubMed ID: 31678742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.
    Simonetti O; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mazzocato S; Kamysz W; Kamysz E; Provinciali M; Giacometti A; Guerrieri M; Offidani A
    Peptides; 2014 May; 55():17-22. PubMed ID: 24531033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of amphipathicity and hydrophobicity in the balance between hemolysis and peptide-membrane interactions of three related antimicrobial peptides.
    Hollmann A; Martínez M; Noguera ME; Augusto MT; Disalvo A; Santos NC; Semorile L; Maffía PC
    Colloids Surf B Biointerfaces; 2016 May; 141():528-536. PubMed ID: 26896660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates.
    Cabassi CS; Sala A; Santospirito D; Alborali GL; Carretto E; Ghibaudo G; Taddei S
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):17. PubMed ID: 28335779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens.
    Oh SH; Park HS; Kim HS; Yun JY; Oh K; Cho YL; Kwak JH
    Int J Antimicrob Agents; 2017 Dec; 50(6):700-706. PubMed ID: 28668680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational Framework for the Design of Trp- and Arg-Rich Peptide Antibiotics Against Multidrug-Resistant Bacteria.
    Xiang W; Clemenza P; Klousnitzer J; Chen J; Qin W; Tristram-Nagle S; Doi Y; Di YP; Deslouches B
    Front Microbiol; 2022; 13():889791. PubMed ID: 35694289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.
    Zheng Z; Tharmalingam N; Liu Q; Jayamani E; Kim W; Fuchs BB; Zhang R; Vilcinskas A; Mylonakis E
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paenibacterin, a novel broad-spectrum lipopeptide antibiotic, neutralises endotoxins and promotes survival in a murine model of Pseudomonas aeruginosa-induced sepsis.
    Huang E; Yousef AE
    Int J Antimicrob Agents; 2014 Jul; 44(1):74-7. PubMed ID: 24802906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An engineered arginine-rich α-helical antimicrobial peptide exhibits broad-spectrum bactericidal activity against pathogenic bacteria and reduces bacterial infections in mice.
    Yang CH; Chen YC; Peng SY; Tsai AP; Lee TJ; Yen JH; Liou JW
    Sci Rep; 2018 Oct; 8(1):14602. PubMed ID: 30279591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.